Pharmaceutical product development :
Collection : Drugs and the pharmaceutical sciences. Mention d'édition :1st ed. Publié par : INFRMA-HC, ([S.l.] :) Détails physiques : 204 p. ; 23 cm. ISBN :0849338271 (hardcover) ($199.95); 9780849338274 (hardcover). Année : 2007| Type de document | Site actuel | Cote | Statut | Date de retour prévue | Code à barres | Réservations |
|---|---|---|---|---|---|---|
| Livre | La bibliothèque des Sciences Médicales et Pharmaceutiques | 615.1 CHI (Parcourir l'étagère) | Disponible | 0000000010633 |
Survol La bibliothèque des Sciences Médicales et Pharmaceutiques Étagères Fermer l'étagère
|
|
|
Pas d'image disponible |
|
|
|
||
| 615.1 BRI Profiles of drug substances, excipients, and related methodology . | 615.1 BUS Antimicrobial therapeutics reviews / | 615.1 CHE Pharmacologie intégrée | 615.1 CHI Pharmaceutical product development : | 615.1 COH Pharmacologie / | 615.1 GAE Molecular chaperones in health and disease | 615.1 HAC Pharmacology : |
During the last two decades, the pharmaceutical industry has been under pressure to reduce development costs and the time needed to bring drugs to market in order to maximize return on investment and bring treatments to patients sooner. To meet these ends, pharmaceutical scientists working in the differing areas of pharmacy, pharmaceutics, and pharmacokinetics are collaborating to address physicochemical and biological issues in the early stages of development to avoid problems in later stages. In Vitro-In Vivo Correlation (IVIVC) is a multidisciplinary tool that has been successfully applied in testing the effectiveness of a drug substance. The only comprehensive guide available on IVIVC, this source illustrates the emerging importance of IVIVC in the drug development process, and covers the most recent advances and regulatory perspectives on the role of IVIVC in the pharmaceutical industry.


Il n'y a pas de commentaire pour ce document.